Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Reviva Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10508
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP5063 for the treatment of schizophrenia disorders. Reviva Pharma’s product RP5063 is also been developing for Parkinson’s psychosis, attention deficit hyperactivity disorder, bipolar disorder, major depressive disorder, Alzheimer’s psychosis and agitation, and autism spectrum. The company also offers clinical trial services. Reviva Pharma is headquartered in Sunnyvale, California, the US.

Reviva Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Reviva Pharma Raises USD1.2 Million in Venture Financing 10
Reviva Pharma Raises USD16 Million in Venture Financing 11
Reviva Pharma Raises US$12 Million In Series 3 Financing Round 12
Reviva Pharmaceuticals Inc – Key Competitors 13
Reviva Pharmaceuticals Inc – Key Employees 14
Reviva Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Jul 21, 2017: Reviva Pharmaceuticals Announces Addition of a New Member to its Board of Directors 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reviva Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Reviva Pharma Raises USD1.2 Million in Venture Financing 10
Reviva Pharma Raises USD16 Million in Venture Financing 11
Reviva Pharma Raises US$12 Million In Series 3 Financing Round 12
Reviva Pharmaceuticals Inc, Key Competitors 13
Reviva Pharmaceuticals Inc, Key Employees 14

List of Figures
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reviva Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ilana Jivago Inc.:企業の戦略・SWOT・財務情報
    Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report Summary Ilana Jivago Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • China Minsheng Banking Corp Ltd:企業の戦略・SWOT・財務情報
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Southwestern Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehe …
  • Genomic Health Inc (GHDX):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • GamaMabs Pharma SA-製薬・医療分野:企業M&A・提携分析
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer. Its lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mullerian hormone (A …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • International Montoro Resources Inc (IMT):企業の財務・戦略的SWOT分析
    Summary International Montoro Resources Inc (International Montoro) is a mining and mineral exploration company. The company provides acquisition, exploration, and development of nickel, copper, cobalt, gold, rare earth elements and uranium mineral prospects, among others. It offers property such as …
  • U.S. HealthWorks Medical Group-製薬・医療分野:企業M&A・提携分析
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health is a healthcare service provider that offers physical therapy, rehabilitation and medical review. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occup …
  • Thomas Cook Group plc:企業の戦略・SWOT・財務情報
    Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cipla Limited:戦略・SWOT・企業財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • Hitachi Zosen Corporation:戦略・SWOT・企業財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ATGen Co Ltd (182400):製薬・医療:M&Aディール及び事業提携情報
    Summary ATGen Co Ltd (ATGen) is a manufacturer and supplier of proteins and monoclonal antibodies. The company offers neuroproteins, enzymes, heat shock proteins, ubiquitins, cancer related proteins, antibodies, viral antigens and hormones. It conducts research and development of medicines based on …
  • Raiffeisen Group:企業の戦略・SWOT・財務情報
    Raiffeisen Group - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • China National Petroleum Corporation:企業の戦略・SWOT・財務分析
    China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Paion AG (PA8):企業の財務・戦略的SWOT分析
    Summary Paion AG (Paion) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs used for out-patient and hospital-based sedation, anesthesia and critical care services. The company’s lead product, remimazolam, is designed for the treatment of patients re …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆